Fidelity Investments’s Inhibikase Therapeutics IKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$281K Buy
2022
Q4
Sell
2022
Q3
$394K Hold
2022
Q2
$322K Hold
2022
Q1
$641K Hold
2021
Q4
$637K Hold
2021
Q3
$823K Hold
2021
Q2
$1.21M Buy
2021
Q1
$601K Hold
2020
Q4
$690K Buy